CLOROX CO /DE/ — Board/Management Information 2013

Aug 19, 2013

8-K 1 clorox_8k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 ________

FORM 8-K

CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2013

THE CLOROX COMPANY (Exact name of registrant as specified in its charter)

---

Delaware	1-07151	31-0595760
(State or other jurisdiction
of	(Commission File Number)	(I.R.S. Employer
incorporation)		Identification
No.)

| 1221 Broadway, Oakland,
California | 94612-1888 |
| --- | --- |
| (Address of principal executive
offices) | (Zip
code) |

(510) 271-7000 (Registrant's telephone number, including area code)

Not applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Item 5.02(d)

On August 14, 2013, the Board of Directors (the “Board”) of The Clorox Company elected Esther Lee to the Board.

A press release announcing the election of Ms. Lee was issued on August 19, 2013, a copy of which is filed as Exhibit 99.1 hereto and is incorporated herein in its entirety.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit	Description
99.1	Press Release dated August 19, 2013 of The Clorox
Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY — By:
Senior Vice
President –
General
Counsel

THE CLOROX COMPANY

FORM 8-K

INDEX TO EXHIBITS

Exhibit	Description
99.1	Press Release
dated August 19, 2013 of The Clorox Company